Cardinal Health/$CAH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cardinal Health
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Ticker
$CAH
Sector
Primary listing
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
48,411
ISIN
US14149Y1082
Website
Cardinal Health Metrics
BasicAdvanced
$40B
26.28
$6.38
0.67
$2.02
1.22%
Price and volume
Market cap
$40B
Beta
0.67
52-week high
$168.44
52-week low
$93.17
Average daily volume
2.2M
Dividend rate
$2.02
Financial strength
Current ratio
0.944
Quick ratio
0.436
Long term debt to equity
-375.975
Total debt to equity
-404.584
Dividend payout ratio (TTM)
31.86%
Interest coverage (TTM)
13.63%
Profitability
EBITDA (TTM)
3,165
Gross margin (TTM)
3.53%
Net profit margin (TTM)
0.70%
Operating margin (TTM)
1.08%
Effective tax rate (TTM)
26.04%
Revenue per employee (TTM)
$4,590,000
Management effectiveness
Return on assets (TTM)
3.13%
Return on equity (TTM)
-60.43%
Valuation
Price to earnings (TTM)
26.277
Price to revenue (TTM)
0.183
Price to book
-13.59
Price to tangible book (TTM)
-2.87
Price to free cash flow (TTM)
16.65
Free cash flow yield (TTM)
6.01%
Free cash flow per share (TTM)
1,006.80%
Dividend yield (TTM)
1.21%
Forward dividend yield
1.22%
Growth
Revenue change (TTM)
0.86%
Earnings per share change (TTM)
155.27%
3-year revenue growth (CAGR)
7.92%
10-year revenue growth (CAGR)
8.55%
3-year earnings per share growth (CAGR)
23.61%
10-year earnings per share growth (CAGR)
6.45%
3-year dividend per share growth (CAGR)
1.00%
10-year dividend per share growth (CAGR)
3.97%
What the Analysts think about Cardinal Health
Analyst ratings (Buy, Hold, Sell) for Cardinal Health stock.
Bulls say / Bears say
Cardinal Health raised its 2025 profit outlook, driven by strong demand for high-cost specialty drugs used to treat complex conditions such as cancer. (reuters.com)
The company reported a 13% increase in fourth-quarter revenue to $53.5 billion, with non-GAAP operating earnings rising 24% to $560 million, indicating robust financial performance. (cardinalhealth.com)
Cardinal Health's strategic acquisitions, including a majority stake in GI Alliance, are expected to enhance its specialty pharmaceutical market presence and drive future growth. (monexa.ai)
The company faces a revenue decline of 4% to 6% in its pharmaceutical unit for fiscal 2025 due to the loss of contracts with UnitedHealth Group's OptumRx, a major client. (reuters.com)
Cardinal Health has been grappling with negative equity, which could pose financial stability concerns despite its revenue growth. (seekingalpha.com)
The company's profit margin lags behind similar peers, indicating potential inefficiencies or pricing pressures in its operations. (seekingalpha.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Jul 2025.
Cardinal Health Financial Performance
Revenues and expenses
Cardinal Health Earnings Performance
Company profitability
Cardinal Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jul15
Cardinal Health
Dividend·Payment
$0.5107Per share
FAQs
What’s the current market cap for Cardinal Health stock?
Cardinal Health (CAH) has a market cap of $40B as of July 08, 2025.
What is the P/E ratio for Cardinal Health stock?
The price to earnings (P/E) ratio for Cardinal Health (CAH) stock is 26.28 as of July 08, 2025.
Does Cardinal Health stock pay dividends?
Yes, the Cardinal Health (CAH) stock pays dividends to shareholders. As of July 08, 2025, the dividend rate is $2.0224 and the yield is 1.22%. Cardinal Health has a payout ratio of 31.86% on a trailing twelve-month basis.
When is the next Cardinal Health dividend payment date?
The next Cardinal Health (CAH) dividend payment is scheduled for July 15, 2025.
What is the beta indicator for Cardinal Health?
Cardinal Health (CAH) has a beta rating of 0.67. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.